🇺🇸 FDA
Patent

US 9346859

Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

granted A61KA61K38/00A61P

Quick answer

US patent 9346859 (Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P35/02